{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:07:44Z","timestamp":1780142864130,"version":"3.54.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adenomyosis, a benign gynecological disease, causes cerebral infarction. Similar to Trousseau\u2019s syndrome, it elevates cancer antigen 125 (CA125) and D-dimer levels; causes hypercoagulability; and results in cerebral infarction. However, no case of adenomyosis causing major cerebral artery occlusion and requiring endovascular thrombectomy has yet been reported. We report on a woman with middle cerebral artery occlusion caused by adenomyosis progression with a benign gynecological tumor and recurrent cerebral infarction. She was successfully treated by endovascular thrombectomy and hysterectomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 48-year-old woman with heavy uterine bleeding was transported by ambulance to our hospital. Upon arrival, she presented with impaired consciousness. Laboratory test results revealed decreased hemoglobin (8.2\u00a0g\/dL) and elevated D-dimer (79.3\u00a0\u00b5g\/mL) levels. Radiological imaging revealed adenomyosis, a left ovarian tumor, multiple uterine myomas, and old and new bilateral renal infarctions. She experienced repeated episodes of excessive menstruation caused by adenomyosis and was scheduled for hysterectomy in 2\u00a0months at another hospital. After hospital admission, uterine bleeding stopped. However, 5\u00a0days after initial bleeding, she had another episode of heavy uterine bleeding and developed left hemiparesis and dysarthria 20\u00a0min later. Brain magnetic resonance imaging revealed bilateral multiple cerebral infarctions indicating right middle cerebral artery occlusion. Thus, endovascular thrombectomy was performed, and anticoagulant therapy was administered. Laboratory test results after thrombectomy revealed elevated CA125 (3536 U\/mL) and CA19-9 (892 U\/mL) levels. She was at a risk of recurrent heavy uterine bleeding leading to repeated cerebral infarction because of anticoagulant treatment. Therefore, we performed hysterectomy and ovariectomy 11\u00a0days after initial bleeding. Histopathological assessment revealed no malignancy. Although she developed asymptomatic pulmonary thromboembolism 14\u00a0days after initial bleeding, D-dimer and tumor marker levels returned to normal soon after gynecological surgery. At 15\u00a0months post-surgery, she had not experienced further ischemic events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Adenomyosis with benign gynecological tumors may be associated with elevated D-dimer and tumor marker levels; excessive menstruation; and anemia. It may cause systemic thromboembolism, including cerebral infarction. To our knowledge, no other study has reported that adenomyosis causes major cerebral artery occlusion requiring endovascular thrombectomy. Hysterectomy may be an effective radical treatment of this condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02045-7","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T08:03:11Z","timestamp":1610352191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Systemic thromboembolism including multiple cerebral infarctions with middle cerebral artery occlusion caused by the progression of adenomyosis with benign gynecological tumor: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Ryo","family":"Aiura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hroo","family":"Yamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotake","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"2045_CR1","first-page":"910.e1-5","volume":"21","author":"K Yamashiro","year":"2012","unstructured":"Yamashiro K, Tanaka R, Nishioka K, Ueno Y, Shimura H, Okuma Y. et al. Cerebral infarcts associated with adenomyosis among middle-aged women. J Stroke Cerebrovasc Dis. 2012;21:910.e1-5.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2045_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12883-018-1117-1","volume":"18","author":"Y Aso","year":"2018","unstructured":"Aso Y, Chikazawa R, Kimura Y, Kimura N, Matsubara E. Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report. BMC Neurol. 2018;18:119.","journal-title":"BMC Neurol"},{"key":"2045_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12883-018-1169-2","volume":"18","author":"K Okazaki","year":"2018","unstructured":"Okazaki K, Oka F, Ishihara H, Suzuki M. Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases. BMC Neurol. 2018;18:166.","journal-title":"BMC Neurol"},{"key":"2045_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12883-018-1213-2","volume":"18","author":"X Yin","year":"2018","unstructured":"Yin X, Wu J, Song S, Zhang B, Chen Y. Cerebral infarcts associated with adenomyosis: a rare risk factor for stroke in middle-aged women: a case series. BMC Neurol. 2018;18:213.","journal-title":"BMC Neurol"},{"key":"2045_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12883-020-01787-0","volume":"20","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhang Y, Yang Y. Acute cerebral infarction with adenomyosis in a patient with fever: a case report. BMC Neurol. 2020;20:210.","journal-title":"BMC Neurol"},{"key":"2045_CR6","doi-asserted-by":"publisher","first-page":"e183-4","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.024","volume":"25","author":"N Hijikata","year":"2016","unstructured":"Hijikata N, Sakamoto Y, Nito C, Matsumoto N, Abe A, Nogami A. et al. Multiple cerebral infarctions in a patient with adenomyosis on hormone replacement therapy: a case report. J Stroke Cerebrovasc Dis. 2016;25:e183-4.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2045_CR7","doi-asserted-by":"publisher","first-page":"e42-5","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.064","volume":"27","author":"K Uchino","year":"2018","unstructured":"Uchino K, Shimizu T, Mizukami H, Isahaya K, Ogura H, Shinohara K. et al. Nonbacterial thrombotic endocarditis complicated by cerebral infarction in a patient with adenomyosis with high serum CA125 level; a case report. J Stroke Cerebrovasc Dis. 2018;27:e42-5.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2045_CR8","first-page":"e50-3","volume":"27","author":"B Kim","year":"2018","unstructured":"Kim B, Kim SH, Kim T. Cerebral infarcts by nonbacterial thrombotic endocarditis associated with adenomyosis: a case report. J Stroke Cerebrovasc Dis. 2018;27:e50-3.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2045_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1447-0756.1992.tb00329.x","volume":"18","author":"YY Kan","year":"1992","unstructured":"Kan YY, Yeh SH, Ng HT, Lou CM. Effect of menstruation on serum CA125 levels. Asia Oceania J Obstet Gynaecol. 1992;18:339 \u2013 43.","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"2045_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/01443615.2013.832178","volume":"34","author":"SS Sheth","year":"2014","unstructured":"Sheth SS, Ray SS. Severe adenomyosis and CA125. J Obstet Gynaecol. 2014;34:79\u201381.","journal-title":"J Obstet Gynaecol"},{"key":"2045_CR11","doi-asserted-by":"publisher","first-page":"733-9","DOI":"10.1016\/S0015-0282(02)03328-9","volume":"78","author":"T Harada","year":"2002","unstructured":"Harada T, Kubota T, Aso T. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril. 2002;78:733-9.","journal-title":"Fertil Steril"},{"key":"2045_CR12","first-page":"193-6","volume":"21","author":"KC Tsao","year":"2007","unstructured":"Tsao KC, Hong JH, Wu TL, Chang PY, Sun CF, Wu JT. Elevation of CA 19 \u2013 9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis. J Clin Lab Anal. 2007;21:193-6.","journal-title":"J Clin Lab Anal"},{"key":"2045_CR13","doi-asserted-by":"publisher","first-page":"1944-5","DOI":"10.1212\/01.WNL.0000163850.07976.63","volume":"64","author":"TG Jovin","year":"2005","unstructured":"Jovin TG, Boosupalli V, Zivkovic SA, Wechsler LR, Gebel JM. High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer. Neurology. 2005;64:1944-5.","journal-title":"Neurology"},{"key":"2045_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/IGC.0b013e31827b8796","volume":"23","author":"F Tas","year":"2013","unstructured":"Tas F, Kilic L, Bilgin E, Keskin S, Sen F, Ciftci R. et al. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2013;23:276 \u2013 81.","journal-title":"Int J Gynecol Cancer"},{"key":"2045_CR15","first-page":"4015-23","volume":"118","author":"B Shao","year":"2011","unstructured":"Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, Xia L. et al. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of trousseau syndrome. Blood. 2011;118:4015-23.","journal-title":"Blood"},{"key":"2045_CR16","doi-asserted-by":"publisher","first-page":"1723-9","DOI":"10.1182\/blood-2006-10-053736","volume":"110","author":"A Varki","year":"2007","unstructured":"Varki A. Trousseau\u2019s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110:1723-9.","journal-title":"Blood"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02045-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-021-02045-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02045-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T08:07:14Z","timestamp":1610352434000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02045-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02045-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}